Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lopinavir/Ritonavir as an Immunomodulator to Enhance Vaccine Responsiveness

NCT01165645 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT01165645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01165645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lopinavir/Ritonavir as an Immunomodulator to Enhance Vaccine Responsiveness
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Withdrawn
Start date
November 30, 2010
Completion date
December 14, 2011
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin lymphoma, stage i adult hodgkin lymphoma, stage ii adult hodgkin lymphoma, stage iii adult hodgkin lymphoma, stage iv adult hodgkin lymphoma